While COVID-19 dramatically spreads across Europe, all companies are being forced to implement new large scale remote working arrangements. During these times of crisis, it’s easy for proprietary and confidential information...more
This month, the Court of Justice of the European Union (CJEU) addressed a case of particular interest for pharmaceutical companies that are in the process of developing a new product. Regulatory and commercial considerations...more
7/19/2019
/ Advertising ,
Appeals ,
Clinical Trials ,
Court of Justice of the European Union (CJEU) ,
General Court of the European Union (GCEU) ,
Intellectual Property Protection ,
Marketing Perspectives ,
Non-Use of Trademarks ,
Pharmaceutical Industry ,
Regulatory Standards ,
Revocation ,
Trademarks